Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   148,092    

Indirect Shares

   6,673      
Direct Value   $4,955,193    

Indirect Value

   $0      
Total Shares   154,765      
Total Value   $4,955,193      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $728,782 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $728,782
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2024-06-04 32,917 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    182         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-02 4 A $0.00 $0 D/D 17,275 40,404 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-02 4 AS $23.01 $198,760 D/D (8,638) 40,493 0 %
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-26 4 B $1.59 $15,856 D/D 10,000 40,644 2.39 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-18 4 AS $130.00 $4,430,140 D/D (34,078) 41,507 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-29 4 D $64.46 $269,701 D/D (4,184) 42,016 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-08-01 4 AS $99.33 $397,320 D/D (4,000) 42,944 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-10-31 4 A $68.44 $10,677 D/D 156 43,100 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-03-11 4 OE $0.00 $0 D/D 19,352 43,709 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-15 4 A $0.00 $0 D/D 13,200 46,200 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-06 4 AS $89.14 $146,992 D/D (1,649) 46,944 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-09-04 4 OE $39.06 $351,540 D/D 9,000 46,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-12-02 4 OE $39.06 $351,540 D/D 9,000 46,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-03 4 D $89.57 $214,520 D/D (2,395) 47,293 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-04-01 4 AS $89.00 $1,199,097 D/D (13,473) 47,510 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-04-30 4 A $68.78 $12,106 D/D 176 47,686 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-11-16 4 OE $39.06 $781,200 D/D 20,000 48,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-03 4 D $90.00 $162,090 D/D (1,801) 48,593 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 15,151 49,131 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-02 4 AS $86.12 $398,120 D/D (4,623) 49,688 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-31 4 AS $89.35 $1,873,126 D/D (20,841) 50,394 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-06-22 4 AS $99.00 $990,005 D/D (10,000) 51,070 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-10-31 4 A $68.78 $12,037 D/D 175 51,245 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-06-13 4 D $3.88 $15,563 D/D (4,011) 52,675 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-02-29 4 D $81.87 $3,828,732 D/D (46,766) 54,311 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-27 4 D $89.09 $383,532 D/D (4,305) 54,339 0 -
  182  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us